Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), reported the sale of 608 common shares on 2026-03-19. The weighted average sale price was $4.79, for a total transaction value of approximately $2,913. This was a sale (S) rather than a purchase.

Key Details

• Transaction date: 2026-03-19; Form 4 filed: 2026-03-20 (appears timely).
• Reported weighted average price: $4.79; individual sale prices ranged from $4.73 to $4.87 (footnote F2).
• Reason: Shares were sold to satisfy tax obligations related to restricted stock units vesting on 2026-03-18; sales were made under a pre-established Rule 10b5-1 trading plan and were non‑discretionary (footnote F1).
• Shares owned after the transaction: not stated in the provided filing excerpt.
• Filing accession: 0001840706-26-000069.

Context

• This sale was conducted to cover tax withholding from RSU vesting and executed under a 10b5-1 plan, which typically indicates a pre-planned, non-discretionary disposition. Such routine tax‑related sales are common and generally less indicative of a change in insider sentiment than voluntary open‑market purchases. The filer offers to provide a breakdown of shares sold at each separate price within the reported range upon written request (per F2).